Motilal Oswal: Q1 FY21 Interim Earnings Review - Healthcare And Technology Beat Earnings Estimates

BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy..Motilal Oswal Report.For the 33 Nifty companies, sales/Ebitda/profit before tax/profit after tax declined 27.7%/1.1%/22.2%/18% (versus estimate decline of 27.3%/5.9%/31.0%/26.1% YoY).Of the 33 Nifty companies that declared their results, on the PAT front, 17 have surpassed, 8 have missed, and 8 have met our expectations.For the Motilal Oswal Financial Services Ltd. (MOFSL) Universe, sales/Ebitda/profit before tax/profit after tax declined 27.5%/6.1%/27.2%/24.5% YoY (versus estimate decline of 27.1%/12%/35.5%/31.6% YoY).The earnings upgrade/downgrade ratio for FY21 so far is skewed in favor of upgrades. 46 MOFSL Universe companies have reported upgrades of more than 3% (of which 36 companies have seen upgrades of more than 10%), while 22 have posted downgrades of more than 3%.Among the Nifty constituents, UltraTech Cement Ltd., Britannia Industries Ltd., Asian Paints Ltd., Hindustan Unilever Ltd., State Bank Of India, Bajaj Finance Ltd., Dr. Reddy’s Laboratories Ltd., Sun Pharmaceuticals Ltd., HCL Technologies Ltd., Infosys Ltd., Tech Mahindra Ltd. and Wipro Ltd.have exceeded our profit estimates.On the flip side, Larsen and Toubro Ltd., ITC Ltd., IndusInd Bank Ltd., Kotak Mahindra Bank Ltd., Reliance Industries Ltd., Tata Consultancy Services Ltd., and UPL Ltd. have missed expectations..Click on the attachment to read the full report:.DISCLAIMERThis report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the brokerage and do not represent the views of BloombergQuint..Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

Motilal Oswal: Q1 FY21 Interim Earnings Review - Healthcare And Technology Beat Earnings Estimates

Motilal Oswal: Q1 FY21 Interim Earnings Review - Healthcare And Technology Beat Earnings Estimates

Choose a plan